Market Cap 3.81B
Revenue (ttm) 0.00
Net Income (ttm) -109.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 4,385,100
Avg Vol 6,990,936
Day's Range N/A - N/A
Shares Out 112.45M
Stochastic %K 60%
Beta 0.64
Analysts Strong Sell
Price Target $88.88

Company Profile

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It develops VK5211, an orally available non-steroidal selectiv...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 704 4660
Address:
9920 Pacific Heights Boulevard, Suite 350, San Diego, United States
MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 6:27 AM
Enter: $VKTX Calls Strike Price: $35 Expiry Date: NOV 14 2025 Buy in Price: $2.70 - $4.60 Sell Price: $3.89 Profit : +44% (Turn every $1 into $1.44) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
DarkOrb
DarkOrb Oct. 25 at 3:40 AM
$VKTX Nothing is forcing BP to make a move. Their stock prices aren't suffering, VKTX stock price isn't running higher, etc. So they can wait for more trial data and more clarity on the obesity marketplace.
1 · Reply
JusKallmeGravy
JusKallmeGravy Oct. 25 at 2:12 AM
$VKTX We all have an opinion or two for what is best for Viking. The unfortunate truth is I pity the fool who gets it exactly right. The unfortunate soul who does will beat her, himself, or its self up for the rest of their life. For not becoming a billionaire if nothing else…not to mention the fact the SEC will be investigating the lucky winner guesser for the next 5 yrs . None the less - What we need is a ranking of the top 10 or 20 possibilities. We can adjust the rankings as things progress. Up or down …maybe Robinhood draft kings will let us take bets on the final 4 …or the eventual winner. I need some help tho…I’m full of ideas and only have two clumsy thumbs. Let’s get a form circulating At least the top ten …but I fear we could mis it completely if we don’t do a top 20 …any long shot can pull a rabbit out of … . Partnership or buy-out are the same value to keep it simple . We need a committee . I have done suggestions.
0 · Reply
saifnila2
saifnila2 Oct. 25 at 1:30 AM
$VKTX jpm actually lowered price to 75 from 80. Go figure. Absolutely nuts. No justification for price reduction, the analysts make this up from whatever they like. This has the potential for double digit billions revenue in a couple of years.
1 · Reply
biolover
biolover Oct. 25 at 1:26 AM
$VKTX the issue If BP understand phase 2 data and extrapolate to approval after all the dump predictions by novo and some analysts on CagriSema , MariTide , orforglipron….that were wrong. Probably as phase 3 trials progress and efficacy , safety leak .. more confidence grows. CEOs such as Bourla were more comfortable taking risk on a few billions. Here we talk about much more. Also Trump Lilly deal should settle uncertainty.
0 · Reply
lakeswim951
lakeswim951 Oct. 25 at 1:12 AM
$VKTX At this point, how can other big pharma companies not named Lilly and Nvo afford not to buy this company🤔
1 · Reply
biolover
biolover Oct. 25 at 12:52 AM
$VKTX clear correlation between SP rise from Sep 30 and the short coverage of 2 M. These shorted shares and daily massive trades by short acounts what is responsible for SP decline last 16 months. 2 M covered shares resulted in about 30% rise in SP ?
0 · Reply
RunGal
RunGal Oct. 25 at 12:46 AM
$VKTX Leerink buy rating…$118.
0 · Reply
FE123
FE123 Oct. 24 at 10:30 PM
$VKTX Short interest down over 2 Million because Deal is on the Way!!
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 24 at 10:14 PM
Enter: $VKTX NOV 14 2025 $35 CALLS Buy in Price: $2.76 - $2.95 Take Profit: $3.39 Stop Bleeding: $2.43 ROI Potential: 23% https://moneygroup.us/
0 · Reply
Latest News on VKTX
Viking Therapeutics: A Speculative Buy

Oct 4, 2025, 9:44 AM EDT - 20 days ago

Viking Therapeutics: A Speculative Buy


Viking Therapeutics: Overdue For Gains

Sep 28, 2025, 2:00 PM EDT - 26 days ago

Viking Therapeutics: Overdue For Gains


Viking: Still On Track, But The Compass Needs Recalibration

Aug 23, 2025, 6:57 AM EDT - 2 months ago

Viking: Still On Track, But The Compass Needs Recalibration


Viking Therapeutics: Panic Creates Opportunity

Aug 20, 2025, 8:52 PM EDT - 2 months ago

Viking Therapeutics: Panic Creates Opportunity


Viking Therapeutics: What's Happening With VKTX Stock?

Aug 20, 2025, 9:50 AM EDT - 2 months ago

Viking Therapeutics: What's Happening With VKTX Stock?


Viking Therapeutics: Still On Track

Aug 18, 2025, 8:56 PM EDT - 2 months ago

Viking Therapeutics: Still On Track


Viking Therapeutics Q2: Confidently Continuing The Recovery

Jul 25, 2025, 10:15 AM EDT - 3 months ago

Viking Therapeutics Q2: Confidently Continuing The Recovery


What's Going On With Viking Therapeutics Stock On Wednesday?

Jun 25, 2025, 1:01 PM EDT - 4 months ago

What's Going On With Viking Therapeutics Stock On Wednesday?


Viking Therapeutics: Buy It For The Future And Ignore The Noise

May 27, 2025, 9:00 AM EDT - 5 months ago

Viking Therapeutics: Buy It For The Future And Ignore The Noise


Viking Therapeutics: Weight-Loss Story Remains Intact

May 22, 2025, 7:24 AM EDT - 5 months ago

Viking Therapeutics: Weight-Loss Story Remains Intact


Viking Therapeutics: Near-Term Catalysts And Competitor Readouts

May 20, 2025, 6:49 AM EDT - 5 months ago

Viking Therapeutics: Near-Term Catalysts And Competitor Readouts


Will Pfizer approach Viking Therapeutics with a buyout proposal?

Apr 15, 2025, 3:26 PM EDT - 6 months ago

Will Pfizer approach Viking Therapeutics with a buyout proposal?


MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 6:27 AM
Enter: $VKTX Calls Strike Price: $35 Expiry Date: NOV 14 2025 Buy in Price: $2.70 - $4.60 Sell Price: $3.89 Profit : +44% (Turn every $1 into $1.44) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
DarkOrb
DarkOrb Oct. 25 at 3:40 AM
$VKTX Nothing is forcing BP to make a move. Their stock prices aren't suffering, VKTX stock price isn't running higher, etc. So they can wait for more trial data and more clarity on the obesity marketplace.
1 · Reply
JusKallmeGravy
JusKallmeGravy Oct. 25 at 2:12 AM
$VKTX We all have an opinion or two for what is best for Viking. The unfortunate truth is I pity the fool who gets it exactly right. The unfortunate soul who does will beat her, himself, or its self up for the rest of their life. For not becoming a billionaire if nothing else…not to mention the fact the SEC will be investigating the lucky winner guesser for the next 5 yrs . None the less - What we need is a ranking of the top 10 or 20 possibilities. We can adjust the rankings as things progress. Up or down …maybe Robinhood draft kings will let us take bets on the final 4 …or the eventual winner. I need some help tho…I’m full of ideas and only have two clumsy thumbs. Let’s get a form circulating At least the top ten …but I fear we could mis it completely if we don’t do a top 20 …any long shot can pull a rabbit out of … . Partnership or buy-out are the same value to keep it simple . We need a committee . I have done suggestions.
0 · Reply
saifnila2
saifnila2 Oct. 25 at 1:30 AM
$VKTX jpm actually lowered price to 75 from 80. Go figure. Absolutely nuts. No justification for price reduction, the analysts make this up from whatever they like. This has the potential for double digit billions revenue in a couple of years.
1 · Reply
biolover
biolover Oct. 25 at 1:26 AM
$VKTX the issue If BP understand phase 2 data and extrapolate to approval after all the dump predictions by novo and some analysts on CagriSema , MariTide , orforglipron….that were wrong. Probably as phase 3 trials progress and efficacy , safety leak .. more confidence grows. CEOs such as Bourla were more comfortable taking risk on a few billions. Here we talk about much more. Also Trump Lilly deal should settle uncertainty.
0 · Reply
lakeswim951
lakeswim951 Oct. 25 at 1:12 AM
$VKTX At this point, how can other big pharma companies not named Lilly and Nvo afford not to buy this company🤔
1 · Reply
biolover
biolover Oct. 25 at 12:52 AM
$VKTX clear correlation between SP rise from Sep 30 and the short coverage of 2 M. These shorted shares and daily massive trades by short acounts what is responsible for SP decline last 16 months. 2 M covered shares resulted in about 30% rise in SP ?
0 · Reply
RunGal
RunGal Oct. 25 at 12:46 AM
$VKTX Leerink buy rating…$118.
0 · Reply
FE123
FE123 Oct. 24 at 10:30 PM
$VKTX Short interest down over 2 Million because Deal is on the Way!!
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 24 at 10:14 PM
Enter: $VKTX NOV 14 2025 $35 CALLS Buy in Price: $2.76 - $2.95 Take Profit: $3.39 Stop Bleeding: $2.43 ROI Potential: 23% https://moneygroup.us/
0 · Reply
raticals
raticals Oct. 24 at 10:07 PM
$VKTX when the story is written on Viking(could be quick or long way off) it’ll be a fascinating read once we are able to learn. I’d imagine at least a dozen suitors, low ball offers, then massive offers. I’d bet a lot there are at least two standing offers at $100+ per share at present.
1 · Reply
biolover
biolover Oct. 24 at 8:28 PM
$VKTX short interest 2 M down. Not seen for a while. Probably slowly realizing will not make money on this ticker. Who is selling to them ?
2 · Reply
bavariaron
bavariaron Oct. 24 at 8:27 PM
$VKTX ** VK2735 Maintenance Study Hidden Value ** Informative piece with cogent analysis and unique insights. Courtesy of @Mufaso7 on X “The #VK2735 Maintenance Study intent which is find out if a monthly SubQ or Weekly Oral or Daily Oral can serve as an effective Weight Maintenance strategy using a reduce amount of API. This study is pioneering as this is a first of its kind study (no one has done a dedicated maintenance study in Obesity.“ https://x.com/mufaso7/status/1981771604121231568?s=46
0 · Reply
JIMMYDAMA
JIMMYDAMA Oct. 24 at 8:19 PM
$VKTX Thank You, Fantastic Article!!
0 · Reply
DG20
DG20 Oct. 24 at 8:12 PM
$VKTX Almost every CC, investor event and data drop has been used to tank the SP for the last 18 months. It was a good week…
1 · Reply
biolover
biolover Oct. 24 at 8:08 PM
$VKTX where interest down 2 M. That is interesting. As off Oct 14
1 · Reply
Duncan_
Duncan_ Oct. 24 at 8:06 PM
0 · Reply
Duncan_
Duncan_ Oct. 24 at 8:00 PM
$VKTX excellent link to article on x: Good read to learn about the latest on maintenance sq to oral. : https://x.com/Mufaso7/status/1981771604121231568
0 · Reply
wal5355
wal5355 Oct. 24 at 7:48 PM
$VKTX This viking is better than a season of Breaking Bad. I can not wait to see how this plays out.
0 · Reply
JIMMYDAMA
JIMMYDAMA Oct. 24 at 7:24 PM
$VKTX trying to Kill the $34 Calls over 1400 traded today Amazing how they spend so much time manipulating! Soon this will be over, I have a feeling real soon! GLTA Have a Great Weekend!
0 · Reply
LastResort
LastResort Oct. 24 at 7:19 PM
$VKTX This isn’t just a short squeeze setup. This is a potential macro trend reversal. It’s extremely rare to see a biotech compress like this with growing fundamentals, positive sentiment, and institutional coverage upgrades still active.
1 · Reply
jmartin795
jmartin795 Oct. 24 at 7:15 PM
$VKTX Nothing Burgers 🍔
0 · Reply